Cargando…

Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway

BACKGROUND: Neonatal bacterial meningitis is a common neonatal disease with high morbidity, and can cause serious sequelae when left untreated. Escherichia coli is the common pathogen, and its endotoxin, lipopolysaccharide (LPS) can damage the endothelial cells, increasing the permeability of the bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Peicen, Yang, Fan, Ding, Yijun, Zhang, Di, Liu, Ying, Zhang, Jinjing, Wu, Dan, Wang, Yajuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533599/
https://www.ncbi.nlm.nih.gov/pubmed/36199030
http://dx.doi.org/10.1186/s12879-022-07752-1
_version_ 1784802379302961152
author Zou, Peicen
Yang, Fan
Ding, Yijun
Zhang, Di
Liu, Ying
Zhang, Jinjing
Wu, Dan
Wang, Yajuan
author_facet Zou, Peicen
Yang, Fan
Ding, Yijun
Zhang, Di
Liu, Ying
Zhang, Jinjing
Wu, Dan
Wang, Yajuan
author_sort Zou, Peicen
collection PubMed
description BACKGROUND: Neonatal bacterial meningitis is a common neonatal disease with high morbidity, and can cause serious sequelae when left untreated. Escherichia coli is the common pathogen, and its endotoxin, lipopolysaccharide (LPS) can damage the endothelial cells, increasing the permeability of the blood-brain barrier (BBB), leading to intracranial inflammation. However, the specific mechanism of bacterial meningitis induced by LPS damaging BBB remains unclear. In this study, the mouse brain microvascular endothelial (bEND.3) cells were used as a research object to investigate whether LPS damage BBB through the PI3K/Akt pathway. METHODS: The bEND.3 cells were stimulated with different concentrations of LPS for 12 h, and the expression of tight junction proteins (ZO-1, claudin-5, occludin) was detected using western blotting. The cells were challenged with the same concentration of LPS (1ug/ml) across different timepoints (0, 2 h, 4 h, 6 h, 12 h, 24 h). Expression of TJ proteins and signal pathway molecules (PI3K, p-PI3K, Akt, p-Akt) were detected. The distribution of ZO-1 in bEND.3 cells were detected by immunofluorescence staining. RESULTS: A negative correlation is observed between ZO-1 and LPS concentration. Moreover, a reduced expression of ZO-1 was most significant under 1 ug/ml of LPS, and the difference was statistically significant (P < 0.05). Additionally, there is a negative correlation between ZO-1 and LPS stimulation time. Meanwhile, the expression of claudin-5 and occludin did not change significantly with the stimulation of LPS concentration and time. The immunofluorescence assay showed that the amount of ZO-1 on the surface of bEND.3 cells stimulated with LPS was significantly lower than that of the control group. After LPS stimulation, p-Akt protein increased at 2 h and peaked at 4 h. The titer of p-PI3K did not change significantly with time. CONCLUSION: LPS can downregulate the expression of ZO-1; however, its effect on claudin-5 and occludin is minimal. Akt signal pathway may be involved in the regulation of ZO-1 expression induced by LPS in bEND.3 cells. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07752-1.
format Online
Article
Text
id pubmed-9533599
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95335992022-10-06 Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway Zou, Peicen Yang, Fan Ding, Yijun Zhang, Di Liu, Ying Zhang, Jinjing Wu, Dan Wang, Yajuan BMC Infect Dis Research BACKGROUND: Neonatal bacterial meningitis is a common neonatal disease with high morbidity, and can cause serious sequelae when left untreated. Escherichia coli is the common pathogen, and its endotoxin, lipopolysaccharide (LPS) can damage the endothelial cells, increasing the permeability of the blood-brain barrier (BBB), leading to intracranial inflammation. However, the specific mechanism of bacterial meningitis induced by LPS damaging BBB remains unclear. In this study, the mouse brain microvascular endothelial (bEND.3) cells were used as a research object to investigate whether LPS damage BBB through the PI3K/Akt pathway. METHODS: The bEND.3 cells were stimulated with different concentrations of LPS for 12 h, and the expression of tight junction proteins (ZO-1, claudin-5, occludin) was detected using western blotting. The cells were challenged with the same concentration of LPS (1ug/ml) across different timepoints (0, 2 h, 4 h, 6 h, 12 h, 24 h). Expression of TJ proteins and signal pathway molecules (PI3K, p-PI3K, Akt, p-Akt) were detected. The distribution of ZO-1 in bEND.3 cells were detected by immunofluorescence staining. RESULTS: A negative correlation is observed between ZO-1 and LPS concentration. Moreover, a reduced expression of ZO-1 was most significant under 1 ug/ml of LPS, and the difference was statistically significant (P < 0.05). Additionally, there is a negative correlation between ZO-1 and LPS stimulation time. Meanwhile, the expression of claudin-5 and occludin did not change significantly with the stimulation of LPS concentration and time. The immunofluorescence assay showed that the amount of ZO-1 on the surface of bEND.3 cells stimulated with LPS was significantly lower than that of the control group. After LPS stimulation, p-Akt protein increased at 2 h and peaked at 4 h. The titer of p-PI3K did not change significantly with time. CONCLUSION: LPS can downregulate the expression of ZO-1; however, its effect on claudin-5 and occludin is minimal. Akt signal pathway may be involved in the regulation of ZO-1 expression induced by LPS in bEND.3 cells. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07752-1. BioMed Central 2022-10-05 /pmc/articles/PMC9533599/ /pubmed/36199030 http://dx.doi.org/10.1186/s12879-022-07752-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zou, Peicen
Yang, Fan
Ding, Yijun
Zhang, Di
Liu, Ying
Zhang, Jinjing
Wu, Dan
Wang, Yajuan
Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway
title Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway
title_full Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway
title_fullStr Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway
title_full_unstemmed Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway
title_short Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway
title_sort lipopolysaccharide downregulates the expression of zo-1 protein through the akt pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533599/
https://www.ncbi.nlm.nih.gov/pubmed/36199030
http://dx.doi.org/10.1186/s12879-022-07752-1
work_keys_str_mv AT zoupeicen lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway
AT yangfan lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway
AT dingyijun lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway
AT zhangdi lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway
AT liuying lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway
AT zhangjinjing lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway
AT wudan lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway
AT wangyajuan lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway